« The Apatosaurus. The Spruce Goose. The Pyramids |
| Marketing Ueber Alles »
July 16, 2002
By Any Other Name
Is it just me, or does it seem a little odd that there was no doubt about what the Pfizer-Pharmacia merged company would be called? Recall that Sandoz and Ciba-Geigy threw two well-established brand names out the window to become Novartis. And Aventis had no choice when it formed; it was such a mouthful that you'd have needed to shrink the letterheads to keep 'em within the margins. GlaxoSmithKline stayed with a modified agglutinative name (note the disappearance of "Beecham" along the way, not to mention "Burroughs-Wellcome.")
Oh well. When Pfizer boarded and captured Warner-Lambert, the joke was that the new company would take the "er" from "Warner" and keep the "Pfiz" from "Pfizer." Maybe the P will be from Pharmacia this time.<
+ TrackBacks (0) | Category: Business and Markets
- RELATED ENTRIES
- Scripps Update
- What If Drug Patents Were Written Like Software Patents?
- Stem Cells: The Center of "Right to Try"
- Speaking of Polyphenols. . .
- Dark Biology And Small Molecules
- How Polyphenols Work, Perhaps?
- More On Automated Medicinal Chemistry
- Scripps Merging With USC?